These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28097323)

  • 1. Folic Acid for the Prevention of Neural Tube Defects: The US Preventive Services Task Force Statement on Folic Acid Supplementation in the Era of Mandatory Folic Acid Fortification.
    Mitchell LE
    JAMA Pediatr; 2017 Mar; 171(3):217-218. PubMed ID: 28097323
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Viswanathan M; Treiman KA; Kish-Doto J; Middleton JC; Coker-Schwimmer EJ; Nicholson WK
    JAMA; 2017 Jan; 317(2):190-203. PubMed ID: 28097361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2009 May; 150(9):626-31. PubMed ID: 19414842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].
    Meijer WM; de Walle HE
    Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2561-4. PubMed ID: 16320666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.
    ; Bibbins-Domingo K; Grossman DC; Curry SJ; Davidson KW; Epling JW; García FA; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Phillips WR; Phipps MG; Pignone MP; Silverstein M; Tseng CW
    JAMA; 2017 Jan; 317(2):183-189. PubMed ID: 28097362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should folic acid fortification be mandatory in Israel?
    Hacohen Y; Lerman-Sagie T
    Isr Med Assoc J; 2006 Sep; 8(9):649-50. PubMed ID: 17058420
    [No Abstract]   [Full Text] [Related]  

  • 7. Folic acid fortification: informed mothers, healthy babies.
    McCaffree J
    J Am Diet Assoc; 2001 Aug; 101(8):872. PubMed ID: 11501857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Periconceptional folic acid prophylaxis and neural tube defects].
    Friberg AK; Jørgensen FS
    Ugeskr Laeger; 2015 Mar; 177(11):. PubMed ID: 25786700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science.
    Bailey LB; Rampersaud GC; Kauwell GP
    J Nutr; 2003 Jun; 133(6):1961S-1968S. PubMed ID: 12771346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Periconceptional folic acid prophylaxis and neural tube defects].
    Friberg AK; Jørgensen FS
    Ugeskr Laeger; 2015 Aug; 177(34):1595-8. PubMed ID: 26565061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of folate for the prevention of neural tube defects: who benefits?
    Bower C; Miller M; Payne J; Serna P
    Paediatr Perinat Epidemiol; 2005 Nov; 19(6):435-44. PubMed ID: 16269071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural tube defects: Risk factors and preventive measures.
    Kondo A; Matsuo T; Morota N; Kondo AS; Okai I; Fukuda H
    Congenit Anom (Kyoto); 2017 Sep; 57(5):150-156. PubMed ID: 28425110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement.
    ; Barry MJ; Nicholson WK; Silverstein M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Li L; Ogedegbe G; Rao G; Ruiz JM; Stevermer J; Tsevat J; Underwood SM; Wong JB
    JAMA; 2023 Aug; 330(5):454-459. PubMed ID: 37526713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of neural tube defects: regional policies in folic acid enrichment and supplementation].
    Wild C; Lehner P; Reiselhuber S; Schiller-Frühwirth I
    Gesundheitswesen; 2010 Dec; 72(12):875-9. PubMed ID: 20198564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neural tube defects in Austria: Assumption and calculations on the prevention potential through folic acid enrichment and supplementation].
    Schiller-Frühwirth I; Mittermayr T; Wild C
    Gesundheitswesen; 2010 Dec; 72(12):880-5. PubMed ID: 20166011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural tube defects: prevalence, etiology and prevention.
    Kondo A; Kamihira O; Ozawa H
    Int J Urol; 2009 Jan; 16(1):49-57. PubMed ID: 19120526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid and the prevention of neural-tube defects.
    Mills JL; Signore CC
    N Engl J Med; 2004 May; 350(21):2209-11; author reply 2209-11. PubMed ID: 15152070
    [No Abstract]   [Full Text] [Related]  

  • 18. Folic acid supplementation to prevent neural tube defects.
    Med Lett Drugs Ther; 2004 Mar; 46(1177):17-8. PubMed ID: 15041889
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of red blood cell folate to intervention: implications for folate recommendations for the prevention of neural tube defects.
    McNulty H; Cuskelly GJ; Ward M
    Am J Clin Nutr; 2000 May; 71(5 Suppl):1308S-11S. PubMed ID: 10799407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of infants with neural tube defects in the presence of folic acid fortification.
    Bol KA; Collins JS; Kirby RS;
    Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.